Anniina Färkkilä

Was a great honour to host Iain McNeish on World Ovarian Cancer Day! And huge congratulations to my student Fernando Perez-Villatoro for successfully defending his PhD #wocd #proudsupervisor @farkkilab.bsky.social @helsinki.fi

@theaacr.bsky.social

Thank you #AACR25!
Was a great hobour to be nominated as a NextGen Star, and give a talk! 🤩 In addition to great science, I particularly enjoyed meeting new people and networking! 👌🏻😍

Immune cell biology - ACIR Journal Articles The latest advances in cancer immunotherapy.

Our recent publication highlighted 🎉 acir.org/journal-arti...

How chemotherapy affects ovarian cancer tumours Researchers have discovered how chemotherapy can change tumours, making them more vulnerable to new types of treatments.

Research led by @afarkkila.bsky.social and @anna-vaharautio.bsky.social from 🇫🇮 @helsinkiuni.bsky.social offers new insights into harnessing the immune system to combat #ovariancancer. The findings could lead to personalized therapies that target the right patients at the right time.

Excited to join the ESSB!

We uncover how standard of care chemotherapy shapes the tumor microenvironment ➡️ #spatialbiology #ovariancancer

New insights into harnessing the immune system to combat ovarian cancer | University of Helsinki Researchers have discovered how chemotherapy can change tumors, making them more vulnerable to new types of treatments. These findings could lead to personalized therapies that target the right patien...

Researchers @helsinkiuni.bsky.social have discovered how chemotherapy can change tumors, making them more vulnerable to new types of treatments.
The findings from @afarkkila.bsky.social & @Vähärautio groups could lead to personalised therapies, offering hope for improving care for ovarian cancer.

New insights into harnessing the immune system to combat ovarian cancer | University of Helsinki Researchers have discovered how chemotherapy can change tumors, making them more vulnerable to new types of treatments. These findings could lead to personalized therapies that target the right patien...

Really happy to share our new publication! @anna-vaharautio.bsky.social Stay tuned for more insights! @farkkilab.bsky.social www.helsinki.fi/en/news/canc...

Single-cell spatial atlas of high-grade serous ovarian cancer unveils MHC class II as a key driver of spatial tumor ecosystems and clinical outcomes The tumor microenvironment (TME) is a complex network of interactions between malignant and host cells, yet its orchestration in advanced high-grade serous ovarian carcinoma (HGSC) remains poorly unde...

New preprint alert ‼️ @farkkilab.bsky.social We generated a single-cell spatial atlas of 280 metastatic #ovariancancer and found tumor MHCII as a key driver of tumor ecosystems and clinical outcomes. www.biorxiv.org/content/10.1...

Can we be added 👋@farkkilab.bsky.social

Mathematical modeling framework enhances clinical trial design for maintenance treatment in oncology - Scientific Reports Scientific Reports - Mathematical modeling framework enhances clinical trial design for maintenance treatment in oncology

New paper published! We modelled PARPi maintenance therapy in #ovariancancer www.nature.com/articles/s41...

Can you add me? and @farkkilab.bsky.social 👋

Matilda presenting her PhD work at NSGO Annual meeting 🎉💪🏼 #ovariancancer #clinicalcancerresrarch @farkkilab.bsky.social

👋 Can I be added?

Hi! Can you add me also to the #spatialbiology starter package thanks!

Congrats Antti &co from thw Nykter Lab 🎉

Hello Bluesky 👋 We
are #hiring; Calling all aspiring #postdoc s: passionate about #spatialbiology, #proteomics, and the #TME? Join our multidisciplinary team in 🇫🇮 to make impactful discoveries in #ovariancancer
🧬 farkkilab.org/careers/job-ads
Sharing appreciated🤗